Published in Blood Weekly, September 22nd, 1997
Most attempts to create a malaria vaccine have focussed on evoking antibodies capable of recognizing malaria parasite (Plasmodium yoelii) sporozoites. Parasites at this stage of the parasite's life cycle are highly sensitive to antibody neutralization.
But New York University researcher Moriya Tsuji noted that sporozoites injected into the bloodstream by the bite of an infected mosquito travel very rapidly to their target cells in the liver, giving antibodies only five minutes to do their job. He and co-workers...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.